Most just lately, it has been discovered that conolidine and the above derivatives act about the atypical chemokine receptor three (ACKR3. Expressed in identical areas as classical opioid receptors, it binds to some wide array of endogenous opioids. As opposed to most opioid receptors, this receptor acts as being a scavenger and will not activate a